Executive record

Stephan Jackman

Director at Alzamend Neuro, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:stephan-jackmanVersion: public-0As of: 2026-09-28

Not yet claimed8 published Claims4 sources
  • Executive
  • Director

Key Claims

Biography

Joined as CEO in November 2018 with extensive experience in therapeutic treatment development from research to commercialization. Previously served as Chief Operating Officer at Ennaid Therapeutics and Exit 9 Technologies, with prior roles at Novartis Pharmaceuticals and L'Oreal USA.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedChief Executive Officer · Alzamend Neuro, Inc.
  2. 2025 to end not publishedExecutive title: Chief Executive Officer and Director · Organization not publishedALZN 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec proxy · Source published: Feb 26, 2026 · Retrieved: Sep 2, 2026

    Supports 1 claim
    • Professional Role: Director at Alzamend Neuro, Inc. · Claim reviewed: Sep 2, 2026

  2. Open source

    sec def 14a · Source published: Feb 26, 2026 · Retrieved: Sep 2, 2026

    Supports 1 claim
    • Professional Role: Chief Executive Officer at Alzamend Neuro, Inc. · Claim reviewed: Sep 2, 2026

  3. ALZN 10-K executive officers

    sec filing · Source published: Jul 22, 2025 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Alzamend Neuro, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Executive Officer and Director · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Alzamend Neuro, Inc. · Claim reviewed: Sep 2, 2026